AstraZeneca has launched a global R&D Postdoctoral Challenge to help accelerate ideas to transform the treatment of some of the world’s most complex diseases. Successful proposals will secure fully funded postdoctoral research positions.
The challenge, launched at EXPO 2020 Dubai, invites final year MD and/or PhD students and postdoctoral researchers from across the world to propose their ideas to help accelerate drug discovery and development across AstraZeneca’s core disease areas.
Shortlisted applicants will have the chance to pitch their research ideas to a panel consisting of AstraZeneca and external life science leaders in October 2022, with the selection of finalists decided later in the year. Proposals will be reviewed based on scientific merit, and potential to create real impact for patients, society and healthcare systems.
Successful candidates will be awarded a fully funded postdoctoral research position and join the scientific community at AstraZeneca. Working alongside a university, the researchers will also receive access to in-house expertise, compounds, novel tools and technologies and mentoring support to develop their ideas and innovate.
Professor Mene Pangalos, Executive Vice President of BioPharmaceuticals R&D at AstraZeneca, said: “The events of the past two years clearly show the need to push the boundaries of medical science has never been more urgent. Rapid progress in disease understanding, as well as scientific and technological advances are genuinely changing our expectations of what is possible. We are delighted to launch the R&D Postdoctoral Challenge to support the next generation of science leaders and help them translate their ideas into meaningful benefits for patients.”
Learn more at: https://openinnovation.astrazeneca.com/rd-postdoctoral-challenge.html